Principles, Techniques, and Applications of T2*-based MR Imaging and Its Special Applications

Published Online:

T2* relaxation is one of the main determinants of image contrast with gradient-echo MR sequences and forms the basis for many T2*-based applications, such as susceptibility-weighted imaging, perfusion MR imaging, functional MR imaging, and iron overload imaging.

T2* relaxation refers to decay of transverse magnetization caused by a combination of spin-spin relaxation and magnetic field inhomogeneity. T2* relaxation is seen only with gradient-echo (GRE) imaging because transverse relaxation caused by magnetic field inhomogeneities is eliminated by the 180° pulse at spin-echo imaging. T2* relaxation is one of the main determinants of image contrast with GRE sequences and forms the basis for many magnetic resonance (MR) applications, such as susceptibility-weighted (SW) imaging, perfusion MR imaging, and functional MR imaging. GRE sequences can be made predominantly T2* weighted by using a low flip angle, long echo time, and long repetition time. GRE sequences with T2*-based contrast are used to depict hemorrhage, calcification, and iron deposition in various tissues and lesions. SW imaging uses phase information in addition to T2*-based contrast to exploit the magnetic susceptibility differences of the blood and of iron and calcification in various tissues. Perfusion MR imaging exploits the signal intensity decrease that occurs with the passage of a high concentration of gadopentetate dimeglumine through the microvasculature. Change in oxygen saturation during specific tasks changes the local T2*, which leads to the blood oxygen level–dependent effect seen at functional MR imaging. The basics of T2* relaxation, T2*-weighted sequences, and their clinical applications are presented, followed by the principles, techniques, and clinical uses of four T2*-based applications, including SW imaging, perfusion MR imaging, functional MR imaging, and iron overload imaging.

© RSNA, 2009


  • 1 Mugler JP. Basic principles. In: Edelman RRHesselink JRZlatkin MBCrues JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders Elsevier, 2006; 23–57. Google Scholar
  • 2 Nitz WR, Reimer P. Contrast mechanisms in MR imaging. Eur Radiol 1999;9:1032–1046. Crossref, MedlineGoogle Scholar
  • 3 Hendrick RE. Image contrast and noise. In: Stark DDBradley WG, eds. Magnetic resonance imaging. 3rd ed. St Louis, Mo: Mosby, 1999; 43–68. Google Scholar
  • 4 Haacke EM, Tkach JA, Parrish TB. Reduction of T2* dephasing in gradient field-echo imaging. Radiology 1989;170:457–462. LinkGoogle Scholar
  • 5 Frahm J, Haenicke W. Rapid scan techniques. In: Stark DDBradley WG, eds. Magnetic resonance imaging. 3rd ed. St Louis, Mo: Mosby, 1999; 87–124. Google Scholar
  • 6 Chavhan GB, Babyn PS, Jankharia BG, Cheng HL, Shroff MM. Steady-state MR imaging sequences: physics, classification, and clinical applications. RadioGraphics 2008;28:1147–1160. LinkGoogle Scholar
  • 7 Edelman RR, Dunkle EE, Wei Li, Kissinger KV, Thangaraj K. Practical considerations and image optimization. In: Edelman RRHesselink JRZlatkin MBCrues JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders Elsevier, 2006; 58–104. Google Scholar
  • 8 Elster AD. Gradient-echo MR imaging: techniques and acronyms. Radiology 1993;186:1–8. LinkGoogle Scholar
  • 9 Tsushima Y, Endo K. Hypointensities in the brain on T2*-weighted gradient-echo magnetic resonance imaging. Curr Probl Diagn Radiol 2006;35: 140–150. Crossref, MedlineGoogle Scholar
  • 10 Thamburaj K, Radhakrishnan VV, Thomas B, Nair S, Menon G. Intratumoral microhemorrhages on T2*-weighted gradient-echo imaging helps differentiate vestibular schwannoma from meningioma. AJNR Am J Neuroradiol 2008;29:552–557. Crossref, MedlineGoogle Scholar
  • 11 Tosaka M, Sato N, Hirato J, et al.. Assessment of hemorrhage in pituitary macroadenoma by T2*-weighted gradient-echo MR imaging. AJNR Am J Neuroradiol 2007;28:2023–2029. Crossref, MedlineGoogle Scholar
  • 12 Rovira A, Orellana P, Alvarez-Sabin J, et al.. Hyper-acute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology 2004;232:466–473. LinkGoogle Scholar
  • 13 Ishiyama K, Hashimoto M, Izumi J, et al.. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors. J Magn Reson Imaging 2008;27:1322–1326. Crossref, MedlineGoogle Scholar
  • 14 Tonan T, Fujimoto K, Azuma S, et al.. Evaluation of small dysplastic nodules and well-differentiated hepatocellular carcinomas with ferucarbotran-enhanced MRI in a 1.0-T MRI unit: utility of T2*-weighted gradient echo sequences with an intermediate-echo time. Eur J Radiol 2007;64:133–139. Crossref, MedlineGoogle Scholar
  • 15 Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272–277. LinkGoogle Scholar
  • 16 Reichenbach JR, Haacke EM. High-resolution BOLD venographic imaging: a window into brain function. NMR Biomed 2001;14:453–467. Crossref, MedlineGoogle Scholar
  • 17 Yamada N, Imakita S, Sakuma T, Takamiya M. Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. Radiology 1996;198:171–178. LinkGoogle Scholar
  • 18 Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–618. Crossref, MedlineGoogle Scholar
  • 19 Tong KA, Ashwal S, Holshouser BA, et al.. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003;227: 332–339. LinkGoogle Scholar
  • 20 Sehgal V, Delproposto Z, Haacke EM, et al.. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22: 439–450. Crossref, MedlineGoogle Scholar
  • 21 Thomas B, Somasundaram S, Thamburaj K, et al.. Clinical applications of susceptibility weighted MR imaging of the brain: a pictorial review. Neuroradiology 2008;50:105–116. Crossref, MedlineGoogle Scholar
  • 22 Li D, Waight DJ, Wang Y. In vivo correlation between blood T2* and oxygen saturation. J Magn Reson Imaging 1998;8:1236–1239. Crossref, MedlineGoogle Scholar
  • 23 Rauscher A, Sedlacik J, Barth M, et al.. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005;26: 736–742. MedlineGoogle Scholar
  • 24 Gupta RK, Rao SB, Rajan J, et al.. Differentiation of calcification from chronic hemorrhage with corrected gradient echo phase imaging. J Comput Assist Tomogr 2001;25:698–704. Crossref, MedlineGoogle Scholar
  • 25 Haacke EM, Cheng NY, House MJ, et al.. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1–25. Crossref, MedlineGoogle Scholar
  • 26 Haacke EM, Ayaz M, Khan A, et al.. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs abnormal iron content in the brain. J Magn Reson Imaging 2007;26: 256–264. Crossref, MedlineGoogle Scholar
  • 27 Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM. Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 2008;29:9–17. Crossref, MedlineGoogle Scholar
  • 28 Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29. LinkGoogle Scholar
  • 29 Alsop D. Perfusion imaging of the brain. In: Edelman RRHesselink JRZlatkin MBCrues JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders Elsevier, 2006; 333–376. Google Scholar
  • 30 Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475–487. MedlineGoogle Scholar
  • 31 Lemort M, Canizares-Perez AC, Van der Stappen A, Kampouridis S. Progress in magnetic resonance imaging of brain tumors. Curr Opin Oncol 2007;19: 616–622. Crossref, MedlineGoogle Scholar
  • 32 Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632–649. LinkGoogle Scholar
  • 33 Law M, Young RJ, Babb JS, et al.. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490–499. LinkGoogle Scholar
  • 34 Emblem KE, Scheie D, Due-Tonnessen P, et al.. Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. AJNR Am J Neuroradiol 2008;29:1664–1670. Crossref, MedlineGoogle Scholar
  • 35 Karonen JO, Liu Y, Vanninen RL, et al.. Combined perfusion- and diffusion-weighted MR imaging in acute ischemic stroke during the 1st week: a longitudinal study. Radiology 2000;217:886–894. LinkGoogle Scholar
  • 36 Rowley HA, Roberts TP. Clinical perspectives in perfusion: neuroradiologic applications. Top Magn Reson Imaging 2004;15:28–40. Crossref, MedlineGoogle Scholar
  • 37 Uludag K, Dubowitz DJ, Buxton RB. Basic principles of functional MRI. In: Edelman RRHesselink JRZlatkin MBCrues JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders Elsevier, 2006; 249–287. Google Scholar
  • 38 Moritz C, Haughton V. Functional MR imaging: paradigms for clinical preoperative mapping. Magn Reson Imaging Clin N Am 2003;11:529–542. Crossref, MedlineGoogle Scholar
  • 39 Petrella JR, Shah LM, Harris KM, et al.. Preoperative functional MR imaging localization of language and motor areas: effect on therapeutic decision making in patients with potentially resectable brain tumors. Radiology 2006;240:793–802. LinkGoogle Scholar
  • 40 Gossuin Y, Muller RN, Gillis P. Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification. NMR Biomed 2004;17: 427–432. Crossref, MedlineGoogle Scholar
  • 41 Wood JC, Ghugre N. MRI assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin 2008;32:85–96. Crossref, MedlineGoogle Scholar
  • 42 Alustiza JM, Artetxe J, Castiella A, et al.. MR quantification of hepatic iron concentration. Radiology 2004;230:479–484. LinkGoogle Scholar
  • 43 Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with beta-thalassemia major. Pediatr Radiol 2007;37:1191–1200. Crossref, MedlineGoogle Scholar
  • 44 Gandon Y, Olivie D, Guyader D, et al.. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004;363:357–362. Crossref, MedlineGoogle Scholar
  • 45 Gandon Y. Hemochromatosis and MRI. Department of Medical Imaging, University Hospital of Rennes Web site. Updated June 10, 2001. Accessed November 1, 2008. Google Scholar
  • 46 St Pierre TG, Clark RR, Chua-anusorn W, et al.. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855–861. Crossref, MedlineGoogle Scholar
  • 47 Anderson LJ, Holden S, Davis B, et al.. Cardiovascular T2-star (T2*) MR for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22: 2171–2179. Crossref, MedlineGoogle Scholar

Article History

Received: Feb 16 2009
Revision received: Mar 13 2009
Revision received: Apr 15 2009
Accepted: May 6 2009
Published in print: Sept 2009